Dr. Jeanne Marrazzo Selected as NIAID’s Next Director
Join us in welcoming Dr. Jeanne Marrazzo to NIAID! She will take up the mantle of NIAID Director this fall, informed by an illustrious research career on the human microbiome, prevention of HIV infection using biomedical interventions, and pathogenesis and management of sexually transmitted diseases. Read our news release NIH Selects Dr. Jeanne Marrazzo as Director of the National Institute of Allergy and Infectious Diseases to learn more.
Collaborate with the AIDS Clinical Trials Group on HIV Remission and Cure
The AIDS Clinical Trials Group (ACTG) is an NIAID-supported network conducting research to improve the treatment of HIV and its co-infections and advance approaches to ultimately cure HIV. ACTG provides an opportunity for collaboration through Small Clinical Trials Advancing HIV Remission and Cure; apply if you have an idea that would help identify a new strategy to address HIV remission and cure. Your proposed trial should be small, with less than 30 participants, but intensive and may include specialized assays and procedures.
Applications are due on October 2, 2023. If you plan to apply, send a required letter of intent by September 5, 2023. Keep in mind, this is not an NIAID notice of funding opportunity; you must follow ACTG’s policies and procedures. Refer to ACTG’s Frequently Asked Questions and direct any inquiries to ACTGLeadershipSupport@DLHCorp.com.
Stream Scientific Meeting on Congenital Cytomegalovirus Vaccine Research
NIAID is hosting a 2-day conference to discuss the current status and challenges for developing and licensing a congenital cytomegalovirus (CMV) vaccine with stakeholders from academia, industry, advocacy groups, and federal agencies. The meeting will take place September 27 and 28, 2023, from 9 a.m. to 4 p.m. Eastern Time. Register to attend virtually at CMV Vaccine Development: How Close Are We?.